We are live on ! Find out more
ZP

Zimmer Partners Portfolio holdings

AUM $4.15B
1-Year Est. Return 14.2%
This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+14.2%
3 Year Est. Return
+57.21%
5 Year Est. Return
+47.82%
10 Year Est. Return
+152.76%
AUM
$6.46B
AUM Growth
-$912M
Cap. Flow
-$878M
Cap. Flow %
-13.59%
Top 10 Hldgs %
45.08%
Holding
174
New
67
Increased
21
Reduced
26
Closed
54

Top Buys

Rank Stock Value
1
D icon
Dominion Energy
D
+$203M
2
AEE icon
Ameren
AEE
+$132M
3
PLD icon
Prologis
PLD
+$108M
4
ESS icon
Essex Property Trust
ESS
+$97.8M
5
EXC icon
Exelon
EXC
+$95.3M

Top Sells

Rank Stock Value
1
LNT icon
Alliant Energy
LNT
+$188M
2
EQIX icon
Equinix
EQIX
+$172M
3
PNW icon
Pinnacle West Capital
PNW
+$166M
4
ES icon
Eversource Energy
ES
+$156M
5
NI icon
NiSource
NI
+$150M

Sector Composition

Rank Sector Weight
1 Utilities 40.76%
2 Real Estate 30.99%
3 Communication Services 8.81%
4 Energy 7.24%
5 Consumer Discretionary 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STEP icon
101
StepStone Group
STEP
$3.65B
$1.33M 0.02%
+50,000
New +$1.28M
OM icon
102
Outset Medical
OM
$80.1M
$1.23M 0.02%
+1,633
New +$1.34M
PRLD icon
103
Prelude Therapeutics
PRLD
$310M
$1.21M 0.02%
+40,000
New +$1.13M
KLRS
104
Kalaris Therapeutics
KLRS
$85.2M
$688K 0.01%
+1,087
New +$742K
RLAY icon
105
Relay Therapeutics
RLAY
$4.06B
$681K 0.01%
+16,000
New +$610K
PLYM
106
DELISTED
Plymouth Industrial REIT
PLYM
$617K 0.01%
+50,000
New +$653K
AMWL icon
107
American Well
AMWL
$185M
$593K 0.01%
+1,000
New +$528K
TSHA icon
108
Taysha Gene Therapies
TSHA
$1.59B
$448K 0.01%
+20,000
New +$470K
SUMO
109
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$436K 0.01%
+20,000
New +$472K
KYMR icon
110
Kymera Therapeutics
KYMR
$9.05B
$404K 0.01%
+12,500
New +$382K
CELL
111
DELISTED
PhenomeX Inc. Common Stock
CELL
$382K 0.01%
+5,000
New +$318K
ALXO icon
112
ALX Oncology
ALXO
$272M
$377K 0.01%
+10,000
New +$393K
LONA
113
LeonaBio Inc
LONA
$69.1M
$369K 0.01%
+2,000
New +$334K
CMPS
114
Compass Pathways
CMPS
$1.52B
$349K 0.01%
+10,000
New +$360K
AFIB
115
DELISTED
Acutus Medical Inc
AFIB
$298K ﹤0.01%
+10,000
New +$304K
CMPI
116
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$288K ﹤0.01%
+25,000
New +$320K
VITL icon
117
Vital Farms
VITL
$569M
$284K ﹤0.01%
+7,000
New +$264K
INZY
118
DELISTED
Inozyme Pharma
INZY
$263K ﹤0.01%
+10,000
New +$248K
DYN icon
119
Dyne Therapeutics
DYN
$4.24B
$202K ﹤0.01%
+10,000
New +$219K
PSTX
120
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$98K ﹤0.01%
+11,000
New +$125K
ACI icon
121
Albertsons Companies
ACI
$5.57B
-3,500,000
Closed -$55.2M
AEP icon
122
American Electric Power
AEP
$72.7B
-1,791,270
Closed -$143M
AM icon
123
Antero Midstream
AM
$10.4B
-437,500
Closed -$2.23M
API
124
Agora
API
$337M
-10,000
Closed -$442K
BNR
125
Burning Rock Biotech
BNR
$99.1M
-2,000
Closed -$540K

Similar funds

Zimmer Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Zimmer Partners held 174 positions worth $6.46B, down 12% from $7.38B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Zimmer Partners withdrew a net $878M in Q3 2020, closing 54 positions and reducing 26 holdings. Its most notable exit was Alliant Energy, an estimated $188M position sold in full.

By sector, the portfolio is most concentrated in Utilities at 41% of assets, down from 42% a quarter earlier, followed by Real Estate and Communication Services.

Against the trend, Zimmer Partners opened a new position in Dominion Energy worth $204M.

  • Zimmer Partners's largest Q3 2020 buy was Dominion Energy: 2,584,286 shares worth $204M.
  • Zimmer Partners added most to American Tower in Q3 2020, an estimated $82.4M increase.
  • Zimmer Partners's biggest Q3 2020 reduction was Pinnacle West Capital, cutting an estimated $166M.
  • Zimmer Partners fully exited Alliant Energy in Q3 2020, selling an estimated $188M.
  • Zimmer Partners's ten largest holdings make up 45% of its $6.46B portfolio in Q3 2020.
  • Zimmer Partners opened 67 new positions and closed 54 in Q3 2020.
  • Zimmer Partners's portfolio value fell 12% quarter-over-quarter to $6.46B.

Based on Zimmer Partners's 13F filing for Q3 2020, filed 16 Nov 2020.